Abstract
Liver biopsy is required when clinically important information about the diagnosis, prognosis or management of a patient cannot be obtained by safer means, or for research purposes. There are several approaches to liver biopsy but predominantly percutaneous or transvenous approaches are used. A wide choice of needles is available and the approach and type of needle used will depend on the clinical state of the patient and local expertise but, for non-lesional biopsies, a 16-gauge needle is recommended. Many patients with liver disease will have abnormal laboratory coagulation tests or receive anticoagulation or antiplatelet medication. A greater understanding of the changes in haemostasis in liver disease allows for a more rational, evidence-based approach to peri-biopsy management. Overall, liver biopsy is safe but there is a small morbidity and a very small mortality so patients must be fully counselled. The specimen must be of sufficient size for histopathological interpretation. Communication with the histopathologist, with access to relevant clinical information and the results of other investigations, is essential for the generation of a clinically useful report.
Reference196 articles.
1. Real-Time Contrast-Enhanced–Guided Biopsy Compared with Conventional Ultrasound–Guided Biopsy in the Diagnosis of Hepatic Tumors on a Background of Advanced Chronic Liver Disease: A Prospective, Randomized, Clinical Trial
2. Guidelines on the use of liver biopsy in clinical practice
3. Neuberger JGA , Day C , Saxseena S . Guidelines on the use of liver biopsy in clinical practice, 2004. https://www.bsg.org.uk/wp-content/uploads/2019/12/BSG-guidelines-on-the-use-of-liver-biopsy-in-clinical-practice.pdf
4. AGREE II: advancing guideline development, reporting and evaluation in health care
5. NICE . Developing NICE guidelines: the manual. NICE, 2018. https://www.nice.org.uk/process/pmg20/chapter/introduction-and-overview
Cited by
164 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献